Quick Answer
Cytosorbents Corp reported Shares Outstanding of 62.80 million shares for fiscal year 2025.
Cytosorbents Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 62.80M | +14.5% |
| 2024 | 54.83M | +1.1% |
| 2023 | 54.24M | +24.3% |
| 2022 | 43.64M | +0.0% |
| 2021 | 43.64M | +1.0% |
| 2020 | 43.22M | +32.5% |
| 2019 | 32.62M | +2.6% |
| 2018 | 31.77M | +9.7% |
| 2017 | 28.97M | +13.7% |
| 2016 | 25.48M | +0.3% |
| 2015 | 25.40M | +9.0% |
| 2014 | 23.30M | +131.8% |
| 2013 | 10.05M | -95.3% |
| 2012 | 214.97M | +21.0% |
| 2011 | 177.63M | +44.6% |
| 2010 | 122.84M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 62.79M | +15.2% | +0.3% |
| June 30, 2025 | 62.61M | +15.3% | +0.1% |
| March 31, 2025 | 62.53M | +15.2% | +14.0% |
| December 31, 2024 | 54.83M | +1.1% | +0.6% |
| September 30, 2024 | 54.50M | +24.3% | +0.4% |
| June 30, 2024 | 54.31M | +23.8% | +0.0% |
| March 31, 2024 | 54.29M | +23.8% | +0.1% |
| December 31, 2023 | 54.24M | +24.3% | +23.7% |
- Cytosorbents Corp showed an increase of +14.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Cytosorbents Corp’s shares outstanding has declined by 48.9% (from 122.84 million shares to 62.80 million shares).
- The most recent figure is from Cytosorbents Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: